Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
Linlin Zhao, Heather L. Ciallella, Lauren M. Aleksunes, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 9, pp. 1624-1638
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Advances in artificial intelligence for drug delivery and development: A comprehensive review
Amol D. Gholap, Md Jasim Uddin, Md. Faiyazuddin, et al.
Computers in Biology and Medicine (2024) Vol. 178, pp. 108702-108702
Closed Access | Times Cited: 37
Revolutionizing Prostate Cancer Therapy: Artificial intelligence – based Nanocarriers for Precision Diagnosis and Treatment
Moein Shirzad, Afsaneh Salahvarzi, Sobia Razzaq, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104653-104653
Closed Access | Times Cited: 3
Harnessing the Power of Artificial Intelligence in Pharmaceuticals: Current Trends and Future Prospects
Saha Aritra, Indu Singh
Intelligent Pharmacy (2025)
Open Access | Times Cited: 2
Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery
Manish Tripathi, Abhigyan Nath, T.P. Singh, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1439-1460
Open Access | Times Cited: 95
Use of artificial intelligence to enhance phenotypic drug discovery
Sophia Malandraki-Miller, Paul R. Riley
Drug Discovery Today (2021) Vol. 26, Iss. 4, pp. 887-901
Closed Access | Times Cited: 57
Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process
Md. Rifat Hasan, Ahad Amer Alsaiari, Burhan Zain Fakhurji, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4169-4169
Open Access | Times Cited: 57
Enhanced-Sampling Simulations for the Estimation of Ligand Binding Kinetics: Current Status and Perspective
Katya Ahmad, Andrea Rizzi, Riccardo Capelli, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 52
Machine Learning in Antibacterial Drug Design
Marko Jukič, Urban Bren
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
Yes SIR! On the structure–inactivity relationships in drug discovery
Edgar López‐López, Eli Fernández‐de Gortari, José L. Medina‐Franco
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2353-2362
Closed Access | Times Cited: 39
Intermolecular Interactions between Nitrosourea and Polyoxometalate compounds
Mohsen Doust Mohammadi, Faheem Abbas, Hitler Louis, et al.
ChemistrySelect (2022) Vol. 7, Iss. 36
Closed Access | Times Cited: 38
Advances in Ultra-High-Resolution Mass Spectrometry for Pharmaceutical Analysis
Estelle Deschamps, Valentina Calabrese, Isabelle Schmitz‐Afonso, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2061-2061
Open Access | Times Cited: 28
Next Generation Risk Assessment approaches for advanced nanomaterials: Current status and future perspectives
Danail Hristozov, Elena Badetti, Paolo Bigini, et al.
NanoImpact (2024) Vol. 35, pp. 100523-100523
Open Access | Times Cited: 11
Exploring innovative strategies for identifying anti-breast cancer compounds by integrating 2D/3D-QSAR, molecular docking analyses, ADMET predictions, molecular dynamics simulations, and MM-PBSA approaches
Said El Rhabori, Marwa Alaqarbeh, Yassine El Allouche, et al.
Journal of Molecular Structure (2024) Vol. 1320, pp. 139500-139500
Closed Access | Times Cited: 9
Discovery of Potential Anthelmintic Agents Against Gyrodactylus kobayashii Through Computer‐Aided Drug Design and In Vivo Evaluation
Jing Dong, Liwei Xia, Yongtao Liu, et al.
Journal of Fish Diseases (2025)
Closed Access | Times Cited: 1
Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay
Silpsiri Sinsulpsiri, Yuji Nishii, Qing‐Feng Xu‐Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs
Sharna-kay Daley, Geoffrey A. Cordell
Molecules (2021) Vol. 26, Iss. 13, pp. 3800-3800
Open Access | Times Cited: 42
Success stories of AI in drug discovery - where do things stand?
Kit‐Kay Mak, Madhu Katyayani Balijepalli, Mallikarjuna Rao Pichika
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 1, pp. 79-92
Closed Access | Times Cited: 42
Revealing Adverse Outcome Pathways from Public High-Throughput Screening Data to Evaluate New Toxicants by a Knowledge-Based Deep Neural Network Approach
Heather L. Ciallella, Daniel P. Russo, Lauren M. Aleksunes, et al.
Environmental Science & Technology (2021) Vol. 55, Iss. 15, pp. 10875-10887
Open Access | Times Cited: 41
From Traditional Herbal Medicine to Rational Drug Discovery: Strategies, Challenges, and Future Perspectives
Dev Bukhsh Singh, Rajesh Kumar Pathak, Dipti Rai
Revista Brasileira de Farmacognosia (2022) Vol. 32, Iss. 2, pp. 147-159
Closed Access | Times Cited: 28
Development of a novel representation of drug 3D structures and enhancement of the TSR-based method for probing drug and target interactions
Tarikul I. Milon, Yuhong Wang, Ryan L. Fontenot, et al.
Computational Biology and Chemistry (2024) Vol. 112, pp. 108117-108117
Closed Access | Times Cited: 7
Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation
Muhammad Yasir, Jinyoung Park, Eun‐Taek Han, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1363-1363
Open Access | Times Cited: 6
Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system
Vertika Gautam, Anand Gaurav, Neeraj Masand, et al.
Molecular Diversity (2022) Vol. 27, Iss. 2, pp. 959-985
Closed Access | Times Cited: 23
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Life (2023) Vol. 13, Iss. 1, pp. 191-191
Open Access | Times Cited: 16
Organochlorine detection on transition metals (X=Zn, Ti, Ni, Fe, and Cr) anchored fullerenes (C23X)
Hitler Louis, Chioma M. Chima, Ismail O. Amodu, et al.
ChemistrySelect (2023) Vol. 8, Iss. 2
Closed Access | Times Cited: 15
Chemical library design, QSAR modeling and molecular dynamics simulations of naturally occurring coumarins as dual inhibitors of MAO-B and AChE
Yassir Boulaamane, Pallavi Kandpal, Anshuman Chandra, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1629-1646
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top